Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Direct ✕Edelweiss Recently Listed IPO Fund · Direct ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseHDFCEdelweiss
NAV₹23.6750₹36.4592
NAV date20 Nov 202620 Nov 2026
History3.1 years8.7 years
Expense ratio1.1%1.4%
Stars★★★★★★★★★★
Growth Score94.5045.20

Returns

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
1 month+12.97%+5.92%
3 months+7.13%+2.40%
6 months+17.84%+20.35%
YTD+33.73%+25.20%
1 year+32.20%+23.75%
3 years (CAGR)+30.70%+17.13%
5 years (CAGR)—+11.04%
10 years (CAGR)——
Since launch+31.83%+15.95%

Risk

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Volatility15.8%20.9%
Downside volatility8.5%12.9%
Sharpe1.530.51
Sortino2.860.82
Calmar2.060.69
Return / risk1.950.82
Deepest fall−14.91%−32.34%
Days to recover126155
Below its high+0.00%−1.63%

Against benchmark

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Alpha+7.54%+5.69%
Beta0.970.97
R²85.0%56.3%
Up capture108.9%114.2%
Down capture71.0%93.5%
Tracking error6.1%13.8%
Information ratio1.170.40
Treynor0.240.10

Consistency

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
Best 1-year+67.01%+98.01%
Middle 1-year+23.25%+17.30%
Worst 1-year+1.71%−23.25%
1-year periods with a loss0.0%23.7%
Middle 3-year+30.22%+18.97%
Positive months72.2%66.7%
Best day+3.18%+3.68%
Worst day−3.61%−5.79%
Worst 5% day−1.51%−1.93%
Positive days58.3%57.6%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundEdelweiss Recently Listed IPO Fund
5-year XIRR—+17.87%
5-year value—₹9,45,521
3-year XIRR+27.71%+18.35%
1-year XIRR+41.37%+35.31%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth